Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
CREATE Medicines is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
IgGenix is a biotechnology company.
Melonfrost is a biotechnology company based in Brooklyn, New York.
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Haystack Oncology enables precision oncology to optimize treatment strategies.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Ozette Technologies is a life science data company that accelerates the development of therapies and diagnostics by digitizing immune data.
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
NextVivo is a biotech company developing an immune organoid technology platform.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Industrial-scale genome sequencing
Alexandria Venture Investments has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Therapeutics, Life Science, Health Care, Medical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Affini-T Therapeutics received $175.0M in a Series Unknown round. Alexandria Venture Investments's total known invested capital is $7.4B.
Alexandria Venture Investments's average investment size is $50.9M across its portfolio of 186 companies.
Recent Alexandria Venture Investments portfolio additions include CREATE Medicines, Function Oncology, Vesigen Therapeutics, QurAlis, Ring Therapeutics. These companies were founded in 2020 or later.